Thymosin β 4 Improves Differentiation and Vascularization of EHTs

Stem Cells International

Volumn 2017, Issue , 2017, Pages

  Ziegler, Tilman ^a,b   Hinkel, Rabea ^a,b,c   Stöhr, Andrea ^d   Eschenhagen, Thomas ^d   Laugwitz, Karl Ludwig ^a   Le Noble, Ferdinand ^e   David, Robert ^f   Hansen, Arne ^b,d   Kupatt, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^f UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOMESODERMIN; MESSENGER RNA; THYMOSIN BETA4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRACHYURY; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIAC MUSCLE; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENGINEERED HEART TISSUE; HEART MUSCLE CONTRACTILITY; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; LYMPHANGIOGENESIS; MESODERMAL CELL; MOUSE; NONHUMAN; ZEBRA FISH;

EID: 85011562596     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2017/6848271     Document Type: Article

References (43)

1. S. Leontyev, F. Schlegel, C. Spath et al., "Transplantation of engineered heart tissue as a biological cardiac assist device for treatment of dilated cardiomyopathy, " European Journal of Heart Failure, vol. 15, no. 1, pp. 23-35, 2013.
2. H. Masumoto, T. Ikuno, M. Takeda et al., "Human iPS cellengineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration, " Scientific Reports, vol. 4, article 6716, 2014.
3. H. Naito, I. Melnychenko, M. Didíe et al., "Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle, " Circulation, vol. 114, no. 1, pp. I72-I78, 2006.
4. M. N. Hirt, A. Hansen, and T. Eschenhagen, "Cardiac tissue engineering: state of the art, " Circulation Research, vol. 114, no. 2, pp. 354-367, 2014.
5. W. J. deLange, L. F. Hegge, A. C. Grimes et al., "Neonatalmousederived engineered cardiac tissue: A novel model system for studying genetic heart disease, " Circulation Research, vol. 109, no. 1, pp. 8-19, 2011.
6. A. Hansen, A. Eder, M. Bönstrup et al., "Development of a drug screening platform based on engineered heart tissue, " Circulation Research, vol. 107, no. 1, pp. 35-44, 2010.
7. W. Zimmermann, K. Schneiderbanger, P. Schubert et al., "Tissue engineering of a differentiated cardiac muscle construct, " Circulation Research, vol. 90, no. 2, pp. 223-230, 2002.
8. M. Tiburcy, M. Didíe, O. Boy et al., "Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue, " Circulation Research, vol. 109, no. 10, pp. 1105-1114, 2011.
9. L. Ye, P. Zhang, S. Duval, L. Su, Q. Xiong, and J. Zhang, "Thymosin 4 increases the potency of transplanted mesenchymal stem cells for myocardial repair, " Circulation, vol. 128, no. 1, pp. S32-S41, 2013.
10. N. Smart, S. Bollini, K. N. Dubé et al., "De novo cardiomyocytes from within the activated adult heart after injury, " Nature, vol. 474, no. 7353, pp. 640-644, 2011.
11. R. Hinkel, T. Trenkwalder, B. Petersen et al., "MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2, " Nature Communications, vol. 5, article 3970, 2014.
12. D. Bongiovanni, T. Ziegler, S. DAlmeida et al., "Thymosin 4 attenuates microcirculatory and hemodynamic destabilization in sepsis, " Expert Opinion on BiologicalTherapy, vol. 15, supplement 1, pp. 203-210, 2015.
13. A. Rossdeutsch, N. Smart, K. N. Dubé, M. Turner, and P. R. Riley, "Essential Role for thymosin 4 in regulating vascular smooth muscle cell development and vessel wall stability, " Circulation Research, vol. 111, no. 4, pp. e89-e102, 2012.
14. C. Mauritz, K. Schwanke, M. Reppel et al., "Generation of functional murine cardiac myocytes from induced pluripotent stem cells, " Circulation, vol. 118, no. 5, pp. 507-517, 2008.
15. N. D. Lawson and B. M. Weinstein, "In vivo imaging of embryonic vascular development using transgenic zebrafish, " Developmental Biology, vol. 248, no. 2, pp. 307-318, 2002.
16. A. Stoehr, M. N. Hirt, A. Hansen et al., "Spontaneous formation of extensive vessel-like structures in murine engineered heart tissue, " Tissue Engineering-Part A, vol. 22, no. 3-4, pp. 326-335, 2016.
17. I. Costello, I.-M. Pimeisl, S. Dräger, E. K. Bikoff, E. J. Robertson, and S. J. Arnold, "The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation, " Nature Cell Biology, vol. 13, no. 9, pp. 1084-1091, 2011.
18. T. Faial, A. S. Bernardo, S. Mendjan et al., "Brachyury and SMADsignalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells, " Development, vol. 142, no. 12, pp. 2121-2135, 2015.
19. A. Bondue and C. Blanpain, "Mesp1: A key regulator of cardiovascular lineage commitment, " Circulation Research, vol. 107, no. 12, pp. 1414-1427, 2010.
20. R. David, C. Brenner, J. Stieber et al., "MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling, " Nature Cell Biology, vol. 10, no. 3, pp. 338-345, 2008.
21. M. Tanaka, Z. Chen, S. Bartunkova, N. Yamasaki, and S. Izumo, "The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development, " Development, vol. 126, no. 6, pp. 1269-1280, 1999.
22. B. Xue, C. Leyrat, J. M. Grimes, and R. C. Robinson, "Structural basis of thymosin-4/profilin exchange leading to actin filament polymerization, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 43, pp. E4596-E4605, 2014.
23. D.-Z. Wang, S. Li, D. Hockemeyer et al., "Potentiation of serumresponse factor activity by a family ofmyocardin-related transcription factors, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 23, pp. 14855-14860, 2002.
24. F. Miralles, G. Posern, A.-I. Zaromytidou, and R. Treisman, "Actin dynamics control SRF activity by regulation of its coactivator MAL, " Cell, vol. 113, no. 3, pp. 329-342, 2003.
25. G. Posern, F. Miralles, S. Guettler, and R. Treisman, "Mutant actins that stabilise F-Actin use distinct mechanisms to activate the SRF coactivator MAL, " EMBO Journal, vol. 23, no. 20, pp. 3973-3983, 2004.
26. H. Akazawa and I. Komuro, "Cardiac transcription factor Csx/Nkx2-5: its role in cardiac development and diseases, " Pharmacology &Therapeutics, vol. 107, no. 2, pp. 252-268, 2005.
27. S. Arsenian, B. Weinhold, M. Oelgeschläger, U. Rüther, and A. Nordheim, "Serum response factor is essential for mesoderm formation during mouse embryogenesis, " EMBO Journal, vol. 17, no. 21, pp. 6289-6299, 1998.
28. B. Weinhold, G. Schratt, S. Arsenian et al., "Srf-/-ES cells display non-cell-Autonomous impairment in mesodermal differentiation, " EMBO Journal, vol. 19, no. 21, pp. 5835-5844, 2000.
29. Y. Nam, K. Song, X. Luo et al., "Reprogramming of human fibroblasts toward a cardiac fate, " Proceedings of the National Academy of Sciences, vol. 110, no. 14, pp. 5588-5593, 2013.
30. B. Yan, R.D. Singla, L. S. Abdelli, P. K. Singal, and D. K. Singla, "Regulation of PTEN/Akt Pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin 4 overexpressing embryonic stem cell transplantation in the infarcted heart, " PLoS ONE, vol. 8, no. 9, Article ID e75580, 2013.
31. L. Qian, Y. Huang, C. I. Spencer et al., "In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes, " Nature, vol. 485, no. 7400, pp. 593-598, 2012.
32. M. Hertzog, C. Van Heijenoort, D. Didry et al., "The-Thymosin/WH2 domain: structural basis for the switch from inhibition to promotion of actin assembly, " Cell, vol. 117, no. 5, pp. 611-623, 2004.
33. K. Yaniv, S. Isogai, D. Castranova, L. Dye, J. Hitomi, and B. M. Weinstein, "Live imaging of lymphatic development in the zebrafish, " Nature Medicine, vol. 12, no. 6, pp. 711-716, 2006.
34. I. Geudens, R. Herpers, K. Hermans et al., "Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1695-1702, 2010.
35. K. Hermans, F. Claes, W. Vandevelde et al., "Role of synectin in lymphatic development in zebrafish and frogs, " Blood, vol. 116, no. 17, pp. 3356-3366, 2010.
36. H. Huang, T. Jin, L. Wang et al., "The RAS guanyl nucleotidereleasing protein rasgrp1 is involved in lymphatic development in zebrafish, "The Journal of Biological Chemistry, vol. 288, no. 4, pp. 2355-2364, 2013.
37. Y. R. Cha, M. Fujita, M. Butler et al., "Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature, " Developmental Cell, vol. 22, no. 4, pp. 824-836, 2012.
38. T. S. Mulligan and B. M. Weinstein, "Emerging from the PAC: studying zebrafish lymphatic development, " Microvascular Research, vol. 96, pp. 23-30, 2014.
39. S. Isogai, M. Horiguchi, and B. M. Weinstein, "The vascular anatomy of the developing zebrafish: An atlas of embryonic and early larval development, " Developmental Biology, vol. 230, no. 2, pp. 278-301, 2001.
40. M. Hanna, H. Liu, J. Amir et al., "Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase, " Journal of Biological Chemistry, vol. 284, no. 34, pp. 23125-23136, 2009.
41. F. Hall-Glenn, R. A. de Young, B.-L. Huang et al., "CCN2/Connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis, " PLoS ONE, vol. 7, no. 2, Article ID e30562, 2012.
42. A. Abramsson, P. Lindblom, and C. Betsholtz, "Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors, " Journal of Clinical Investigation, vol. 112, no. 8, pp. 1142-1151, 2003.
43. R. Hinkel, C. El-Aouni, T. Olson et al., "Thymosin 4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection, " Circulation, vol. 117, no. 17, pp. 2232-2240, 2008.